
Sign up to save your podcasts
Or


In this episode of Beyond the Data, we are joined by renowned critical care nephrology expert Prof. John Kellum for a discussion on two important recent trials: TIGRIS, evaluating polymyxin B haemoadsorption in septic shock, and ICRAKI, comparing intermittent haemodialysis with continuous renal replacement therapy in critically ill patients with AKI.
We go beyond the trial results to explore the physiological rationale, methodological considerations, clinical implications and what these findings mean for the future of critical care nephrology.
A thought-provoking conversation on interpreting evidence and translating it into better clinical decisions.
In the first episode of Season 2, we discuss the recently published ICRAKI trial that compared intermittent vs. continuous renal replacement therapy for critically ill patients. We discuss the trial rationale and background, review the methods and results, and offer our critical interpretation. We also briefly discuss non-inferiority trial designs and the nuances involved in interpretation.
Available on Apple, YouTube, Amazon, and Spotify.
In this 10th episode of our podcast, we discuss the recently published BIHCA trial that evaluated sodium bicarbonate for in-hospital cardiac arrest. As always, we discuss the rationale, PICO, results, limitations and provide our interpretation and take-aways.
Available on Apple, Spotify, and YouTube.
If you have been enjoying, please comment, like, subscribe, and share!
In this BTD episode, we are joined by senior neurosurgeon and neuro-endovascular intervention specialist Dr. Srinivasan Paramasivam.
We unpack the rationale, indications, and evolution of evidence behind middle meningeal artery embolization, along with key technical nuances, clinical decision-making, and real-world challenges.
Listen to this episode alongside our discussion on the STEM trial for full context on the evolving evidence in chronic subdural hematoma management.
Available on Apple, Spotify, Amazon, and YouTube.
Remember to like, comment, subscribe, and share!
In this episode, we review the evidence on middle meningeal artery embolization for chronic subdural hematoma, with a deep dive into the STEM trial and a brief overview of other key studies. Alongside a critical appraisal of the clinical trials, we also include a short methods segment on stratification in the context of randomization.
Our podcast is available on Apple, Spotify, and YouTube. If you are listening on Apple or Spotify, please note that the YouTube version includes images and text overlays that may further aid understanding of the trials discussed.
If you have been enjoying our content, please like, comment, subscribe, and share!
In this episode, we review the LOGICAL trial, which compared conservative versus liberal oxygenation targets in patients admitted to the ICU following cardiac arrest. We discuss the underlying rationale, summarize prior evidence, and examine the trial in detail. We also include a methods segment on response-adaptive randomization, before concluding with a discussion of the study’s strengths and limitations.
Our podcast is available on Apple, Spotify, and YouTube.
If you enjoy our content, please like, comment, and subscribe—it really helps us reach a wider audience. Thank you!
In this episode, we break down the recently published SODa-BIC trial, exploring the role of IV sodium bicarbonate in critically ill patients with metabolic acidemia. We walk through the rationale, prior evidence, PICO, results, and our key critiques and takeaways. We also include a short methods segment on adaptive sample size re-estimation.
You can also find us on Apple Podcasts and Spotify.
In this episode, we review the recently published ARISE-Fluids trial, which compared a restrictive fluid strategy with early vasopressor use against a more liberal fluid approach with delayed vasopressors. We place the trial in context, discuss the prior evidence, and unpack the key findings. We also use the study as a springboard to introduce “time-to-event” outcomes, before reflecting on the trial’s strengths and limitations.
Our podcast is available on Apple, Spotify, and YouTube.
You can also explore our methods blog at: ccmevidence.blog
In this 2nd episode of BTD, we speak with Dr. Nandini Sethuraman, Chief of Microbiology at the Apollo Central Reference Laboratory in Chennai. We discuss microbiology lab workflows, the different methods involved in species identification and susceptibility testing, common pitfalls, and also her take on the FAST trial!
In this episode, we discuss the FAST trial that compared a new and rapid antibiotic susceptibility test to standard practice. We discuss the rationale, trial design, the DOOR outcome framework and its analytical approach, and the limitations.
From the publisher's feed
Our take on the latest critical care evidence with deep insights on methods, interpretation, clinical relevance and so much more!
CRITKNOW is co-hosted by Bharath Kumar…
Bharath is a mid-career clinician–researcher with a primary focus on improving outcomes from critical illness in patients in low- and middle-income countries (LMICs). He is also deeply passionate about teaching evidence-based medicine and helping clinicians interpret and apply emerging evidence in patient care. You can learn more about his work here: https://www.researchgate.net/profile/Bharath-Kumar-Tirupakuzhi-Vijayaraghavan?ev=hdr_xprf
Ramesh is American Board–certified in Internal Medicine, Critical Care Medicine, and Neurocritical Care. He is also a senior researcher with a special interest in acute kidney injury and renal replacement therapy. A highly respected teacher and educator, he has a unique ability to integrate emerging evidence into bedside clinical practice. You can learn more about his work here: https://icuconsultants.com/dr-ramesh-venkataraman/
Bharath and Ramesh are both Senior Consultants in the Department of Critical Care Medicine at Apollo Hospitals, Chennai and affiliated with Chennai Critical Care Consultants Private Limited, an academic critical care group practice (https://icuconsultants.com/). Bharath is also affiliated with the University of Edinburgh as a Clinical Research Fellow (https://inflammation-research.ed.ac.uk/research/research-groups/dr-bharath-kumar)
Views expressed are personal.